Oxy-nitroso shielding burst model of cold atmospheric plasma therapeutics

Clinical Plasma Medicine

Volumn 2, Issue 2, 2014, Pages 38-49

  Graves, David B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bystander effect; Cold atmospheric plasma; Hormesis; Plasma medicine; Reactive oxygen and nitrogen species

Indexed keywords

DOXORUBICIN; FLUOROURACIL; PACLITAXEL; PROTEASOME; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UBIQUITIN;

ADAPTIVE BEHAVIOR; AEROBIC METABOLISM; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CALORIC RESTRICTION; CANCER CELL LINE; CELL COMMUNICATION; CELL SURVIVAL; CELLULAR STRESS RESPONSE; CLINICAL EFFECTIVENESS; COLD ATMOSPHERIC PRESSURE THERAPY; CROSS RESISTANCE; DNA DAMAGE; HUMAN; INNATE IMMUNITY; IONIZING RADIATION; LIPID PEROXIDATION; MEDICAL RESEARCH; NONHUMAN; OXIDATION; OXIDATIVE SHIELDING; OXIDATIVE STRESS; OXYGEN BLOOD LEVEL; OXYNITROSO SHIELDING BURST MODEL; PROCESS MODEL; REVIEW; THERAPY; TISSUE INTERACTION;

EID: 84915763484     PISSN: 22128166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpme.2014.11.001     Document Type: Review

References (98)

1. Von Woedtke T, Metelmann H-R, Weltmann K-D. Clinical plasma medicine: state and perspectives of in vivo application of cold atmospheric plasma. Contrib Plasma Phys 2014, 54:104-117. 10.1002/ctpp.201310068.
2. Schlegel J, Köritzer J, Boxhammer V. Plasma in cancer treatment. Clin Plasma Med 2013, 1:2-7. 10.1016/j.cpme.2013.08.001.
3. Graves DB. The emerging role of reactive oxygen and nitrogen species in redox biology and some implications for plasma applications to medicine and biology. J Phys D Appl Phys 2012, 45:263001. 10.1088/0022-3727/45/26/263001.
4. Brullé L, Vandamme M, Riès D, Martel E, Robert E, Lerondel S, et al. Effects of a non thermal plasma treatment alone or in combination with gemcitabine in a MIA PaCa2-luc orthotopic pancreatic carcinoma model. PLoS One 2012, 7:e52653. 10.1371/journal.pone.0052653.
5. Kalghatgi S, Kelly CM, Cerchar E, Torabi B, Alekseev O, Fridman A, et al. Effects of non-thermal plasma on mammalian cells. PLoS One 2011, 6:e16270. 10.1371/journal.pone.0016270.
6. Wende K, Straßenburg S, Haertel B, Harms M, Holtz S, Barton A, et al. Atmospheric pressure plasma jet treatment evokes transient oxidative stress in HaCaT keratinocytes and influences cell physiology. Cell Biol Int 2014, 38:412-425. 10.1002/cbin.10200.
7. Zhao S, Xiong Z, Mao X, Meng D, Lei Q, Li Y, et al. Atmospheric pressure room temperature plasma jets facilitate oxidative and nitrative stress and lead to endoplasmic reticulum stress dependent apoptosis in HepG2 cells. PLoS One 2013, 8:e73665. 10.1371/journal.pone.0073665.
8. Vandamme M, Robert E, Pesnel S, Barbosa E, Dozias S, Sobilo J, et al. Antitumor effect of plasma treatment on U87 glioma xenografts: preliminary results. Plasma Process Polym 2010, 7:264-273. 10.1002/ppap.200900080.
9. Walk RM, Snyder J a, Srinivasan P, Kirsch J, Diaz SO, Blanco FC, et al. Cold atmospheric plasma for the ablative treatment of neuroblastoma. J Pediatr Surg 2013, 48:67-73. 10.1016/j.jpedsurg.2012.10.020.
10. Matthes R, Bender C, Schlüter R, Koban I, Bussiahn R, Reuter S, et al. Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms. PLoS One 2013, 8:e70462. 10.1371/journal.pone.0070462.
11. Lademann J, Ulrich C, Patzelt A, Richter H, Kluschke F, Klebes M, et al. Risk assessment of the application of tissue-tolerable plasma on human skin. Clin Plasma Med 2013, 1:5-10. 10.1016/j.cpme.2013.01.001.
12. Fluhr JW, Sassning S, Lademann O, Darvin ME, Schanzer S, Kramer A, et al. In vivo skin treatment with tissue-tolerable plasma influences skin physiology and antioxidant profile in human stratum corneum. Exp Dermatol 2012, 21:130-134. 10.1111/j.1600-0625.2011.01411.x.
13. Partecke LI, Evert K, Haugk J, Doering F, Normann L, Diedrich S, et al. Tissue tolerable plasma (TTP) induces apoptosis in pancreatic cancer cells in vitro and in vivo. BMC Cancer 2012, 12:473. 10.1186/1471-2407-12-473.
14. Szili EJ, Bradley JW, Short RD. A tissue model to study the plasma delivery of reactive oxygen species. J Phys D Appl Phys 2014, 47:152002. 10.1088/0022-3727/47/15/152002.
15. Barekzi N, Laroussi M. Effects of low temperature plasmas on cancer cells. Plasma Process Polym 2013, 10:1039-1050. 10.1002/ppap.201300083.
16. Villacorta L, Chang L, Salvatore SR, Ichikawa T, Zhang J, Petrovic-Djergovic D, et al. Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts. Cardiovasc Res 2013, 98:116-124. 10.1093/cvr/cvt002.
17. Tidwell TT. The Gomberg century: free radicals. Adv Phys Org Chem 2001, 36:1-58. 10.1016/S0065-3160(01)36002-1.
18. Michaelis L. Occurrence and significance of semiquinone radicals. Ann NY Acad Sci 1940, 39-76.
19. Michaelis L. Theory of the reversible two-step oxidation. J Biol Chem 1932, 703-715.
20. Commoner B, Townsend J, Pake G. Free radicals in biological materials. Nature 1954.
21. Gerschman R, Gilbert D. Oxygen poisoning and x-irradiation: a mechanism in common. Sci Aging. 2005, 623-626.
22. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956, 11:298-300.
23. Harman D. Free radical theory of aging: origin of life, evolution, and aging. Age (Omaha) 1980, 3:100-102. 10.1007/BF02432267.
24. Niki E. Free radicals in the 1900s: from in vitro to in vivo. Free Radic Res 2000, 33:693-704. 10.1080/10715760000301221.
25. Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007, 39:44-84. 10.1016/j.biocel.2006.07.001.
26. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 2002, 82:47-95. 10.1152/physrev.00018.2001.
27. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007, 87:315-424. 10.1152/physrev.00029.2006.
28. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 2005, 24:55-99. 10.1002/mas.20006.
29. Davies KJ. Oxidative stress: the paradox of aerobic life. Biochem Soc Symp 1995, 61:1-31.
30. Halliwell B. The wanderings of a free radical. Free Radic Biol Med 2009, 46:531-542. 10.1016/j.freeradbiomed.2008.11.008.
31. Adler V, Yin Z, Tew KD, Ronai Z. Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111. 10.1038/sj.onc.1203128.
32. Lapointe J, Hekimi S. When a theory of aging ages badly. Cell Mol Life Sci 2010, 67:1-8. 10.1007/s00018-009-0138-8.
33. Hekimi S, Lapointe J, Wen Y. Taking a good look at free radicals in the aging process. Trends Cell Biol 2011, 21:569-576. 10.1016/j.tcb.2011.06.008.
34. Sohal RS, Orr WC. The redox stress hypothesis of aging. Free Radic Biol Med 2012, 52:539-555. 10.1016/j.freeradbiomed.2011.10.445.
35. Ristow M, Schmeisser K. Mitohormesis: promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose Response 2014, 12:288-341. 10.2203/dose-response.13-035.Ristow.
36. Calabrese EJ. Converging concepts: adaptive response, preconditioning, and the Yerkes-Dodson law are manifestations of hormesis. Ageing Res Rev 2008, 7:8-20. 10.1016/j.arr.2007.07.001.
37. Speciale a, Chirafisi J, Saija A, Cimino F. Nutritional antioxidants and adaptive cell responses: an update. Curr Mol Med 2011, 11:770-789.
38. Brun P, Vono M, Venier P, Tarricone E, Deligianni V, Martines E, et al. Disinfection of ocular cells and tissues by atmospheric-pressure cold plasma. PLoS One 2012, 7:e33245. 10.1371/journal.pone.0033245.
39. Naviaux RK. Oxidative shielding or oxidative stress?. J Pharmacol Exp Ther 2012, 342:608-618. 10.1124/jpet.112.192120.
40. Milisav I, Poljsak B, Suput D. Adaptive response, evidence of cross-resistance and its potential clinical use. Int J Mol Sci 2012, 13:10771-10806. 10.3390/ijms130910771.
41. Ward J. DNA damage as the cause of ionizing radiation-induced gene activation. Radiat Res 1994, 138.
42. Mikkelsen RB, Wardman P. Biological chemistry of reactive oxygen and nitrogen and radiation-induced signal transduction mechanisms. Oncogene 2003, 22:5734-5754. 10.1038/sj.onc.1206663.
43. Spitz DR, Azzam EI, Li JJ, Gius D. Metabolic oxidation/reduction reactions and cellular responses to ionizing radiation: a unifying concept in stress response biology. Cancer Metastasis Rev 2004, 23:311-322. 10.1023/B:CANC.0000031769.14728.bc.
44. Prise KM, O'Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer 2009, 9:351-360. 10.1038/nrc2603.
45. Klammer H, Mladenov E, Li F, Iliakis G. Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative status. Cancer Lett 2013, 10.1016/j.canlet.2013.12.017.
46. Matsuzawa A, Ichijo H. Stress-responsive protein kinases in redox-regulated apoptosis signaling. Antioxid Redox Signal 2005, 7:472-481.
47. Ermakov A V, Konkova MS, Kostyuk S V, Izevskaya VL, Baranova A, Veiko NN. Oxidized extracellular DNA as a stress signal in human cells. Oxid Med Cell Longev 2013, 2013:649747. 10.1155/2013/649747.
48. Boonstra J, Post JA. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 2004, 337:1-13. 10.1016/j.gene.2004.04.032.
49. Kültz D. Molecular and evolutionary basis of the cellular stress response. Annu Rev Physiol 2005, 67:225-257. 10.1146/annurev.physiol.67.040403.103635.
50. Raedschelders K, Ansley DM, DDY Chen The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther 2012, 133:230-255. 10.1016/j.pharmthera.2011.11.004.
51. Murry CE, Jennings RB, Reimer KA Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74:1124-1136. 10.1161/01.CIR.74.5.1124.
52. Sun JZ, Tang XL, Park SW, Qiu Y, Turrens JF, Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 1996, 97:562-576. 10.1172/JCI118449.
53. Ajamieh HH, Menéndez S, Martínez-Sánchez G, Candelario-Jalil E, Re L, Giuliani A, et al. Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion. Liver Int 2004, 24:55-62. 10.1111/j.1478-3231.2004.00885.x.
54. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, et al. Ozone oxidative preconditioning protects the rat kidney from reperfusion injury: the role of nitric oxide. J Surg Res 2008, 149:287-295. 10.1016/j.jss.2007.12.756.
55. León OS, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 1998, 7:289-294. 10.1080/09629359890983.
56. Gultekin FA, Bakkal BH, Guven B, Tasdoven I, Bektas S, Can M, et al. Effects of ozone oxidative preconditioning on radiation-induced organ damage in rats. J Radiat Res 2013, 54:36-44. 10.1093/jrr/rrs073.
57. Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014, 94:909-950. 10.1152/physrev.00026.2013.
58. Silachev DN, Plotnikov EY, Pevzner IB, Zorova LD, Babenko V a, Zorov SD, et al. The mitochondrion as a key regulator of ischaemic tolerance and injury. Heart Lung Circ 2014, 23:897-904. 10.1016/j.hlc.2014.05.022.
59. Yan L-J. Positive oxidative stress in aging and aging-related disease tolerance. Redox Biol 2014, 2:165-169. 10.1016/j.redox.2014.01.002.
60. Yan L-J. Protein redox modification as a cellular defense mechanism against tissue ischemic injury. Oxid Med Cell Longev 2014, 2014:343154. 10.1155/2014/343154.
61. Bocci V a, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med 2011, 9:66. 10.1186/1479-5876-9-66.
62. Graves DB. Reactive species from cold atmospheric plasma: implications for cancer therapy. Plasma Process Polym n.d.:1-16.
63. Leach JK, Van Tuyle G, Lin PS, Schmidt-Ullrich R, Mikkelsen RB. Ionizing radiation-induced, mitochondria-dependent generation of reactive oxygen/nitrogen. Cancer Res 2001, 61:3894-3901.
64. Mroz P, Yaroslavsky A, Kharkwal GB, Hamblin MR. Cell death pathways in photodynamic therapy of cancer. Cancers (Basel) 2011, 3:2516-2539. 10.3390/cancers3022516.
65. Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 2009, 11:3013-3069. 10.1089/ARS.2009.2541.
66. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery 2013, 12:931-947. 10.1038/nrd4002.
67. Katschinski DM, Boos K, Schindler SG, Fandrey J. Pivotal role of reactive oxygen species as intracellular mediators of hyperthermia-induced apoptosis. J Biol Chem 2000, 275:21094-21098. 10.1074/jbc.M001629200.
68. Moon EJ, Sonveaux P, Porporato PE, Danhier P, Gallez B, Batinic-Haberle I, et al. NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperthermia treatment. Proc Natl Acad Sci USA 2010, 107:20477-20482. 10.1073/pnas.1006646107.
69. Kohanski MA, Dwyer DJ, Collins JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 2010, 8:423-435. 10.1038/nrmicro2333.
70. Delattin N, Cammue BP a, Thevissen K. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem 2014, 6:77-90. 10.4155/fmc.13.189.
71. Docampo R, Moreno SN. Free radical metabolites in the mode of action of chemotherapeutic agents and phagocytic cells on Trypanosoma cruzi. Rev Infect Dis 2014, 6:223-238.
72. Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol 2013, 3:120144. 10.1098/rsob.120144.
73. Rubartelli A, Lotze MT, Latz E, Manfredi A. Mechanisms of sterile inflammation. Front Immunol 2013, 4:398. 10.3389/fimmu.2013.00398.
74. Chovatiya R, Medzhitov R. Stress, inflammation, and defense of homeostasis. Mol Cell 2014, 54:281-288. 10.1016/j.molcel.2014.03.030.
75. Torres M, Jones J, Dangl J. Reactive oxygen species signaling in response to pathogens. Plant Physiol 2006, 141:373-378. 10.1104/pp.106.079467.
76. Niethammer P, Grabher C, Look a T, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 2009, 459:996-999. 10.1038/nature08119.
77. Frey B, Rubner Y, Kulzer L, Werthmöller N, Weiss E-M, Fietkau R, et al. Antitumor immune responses induced by ionizing irradiation and further immune stimulation. Cancer Immunol Immunother 2014, 63:29-36. 10.1007/s00262-013-1474-y.
78. Durante M, Reppingen N, Held KD. Immunologically augmented cancer treatment using modern radiotherapy. Trends Mol Med 2013, 19:565-582. 10.1016/j.molmed.2013.05.007.
79. Formenti SC, Demaria S. Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst 2013, 105:256-265. 10.1093/jnci/djs629.
80. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006, 6:535-545. 10.1038/nrc1894.
81. Collet G, Robert E, Lenoir a, Vandamme M, Darny T, Dozias S, et al. Plasma jet-induced tissue oxygenation: potentialities for new therapeutic strategies. Plasma Sources Sci Technol 2014, 23:012005. 10.1088/0963-0252/23/1/012005.
82. Kevil CG, Kolluru GK, Pattillo CB, Giordano T. Inorganic nitrite therapy: historical perspective and future directions. Free Radic Biol Med 2011, 51:576-593. 10.1016/j.freeradbiomed.2011.04.042.
83. Quain J. Ozone treatment of wounds. Lancet 1940, 1028-1029.
84. Stoker G. The surgical uses of ozone. Lancet 1916, 188:712. 10.1016/S0140-6736(01)31717-8.
85. Wang M, Holmes B, Cheng X, Zhu W, Keidar M, Zhang LG. Cold atmospheric plasma for selectively ablating metastatic breast cancer cells. PLoS One 2013, 8:e73741. 10.1371/journal.pone.0073741.
86. Utsumi F, Kajiyama H, Nakamura K, Tanaka H, Mizuno M, Ishikawa K, et al. Effect of indirect nonequilibrium atmospheric pressure plasma on anti-proliferative activity against chronic chemo-resistant ovarian cancer cells in vitro and in vivo. PLoS One 2013, 8:e81576. 10.1371/journal.pone.0081576.
87. Alexandre J, Hu Y, Lu W, Pelicano H, Huang P. Novel action of paclitaxel against cancer cells: bystander effect mediated by reactive oxygen species. Cancer Res 2007, 67:3512-3517. 10.1158/0008-5472.CAN-06-3914.
88. Purschke M, Laubach H-J, Anderson RR, Manstein D. Thermal injury causes DNA damage and lethality in unheated surrounding cells: active thermal bystander effect. J Invest Dermatol 2010, 130:86-92. 10.1038/jid.2009.205.
89. Klammer H, Mladenov E, Li F, Iliakis G. Bystander effects as manifestation of intercellular communication of DNA damage and of the cellular oxidative status. Cancer Lett 2014, 10.1016/j.canlet.2013.12.017.
90. Lazović S, Maletić D, Leskovac a., Filipović J, Puač N, Malović G, et al. Plasma induced DNA damage: comparison with the effects of ionizing radiation. Appl Phys Lett 2014, 105:124101. 10.1063/1.4896626.
91. Ishaq M, Kumar S, Varinli H, Han ZJ, Rider AE, Evans MDM, et al. Atmospheric gas plasma-induced ROS production activates TNF-ASK1 pathway for the induction of melanoma cancer cell apoptosis. Mol Biol Cell 2014, 25:1523-1531. 10.1091/mbc.E13-10-0590.
92. Arndt S, Wacker E, Li Y-F, Shimizu T, Thomas HM, Morfill GE, et al. Cold atmospheric plasma, a new strategy to induce senescence in melanoma cells. Exp Dermatol 2013, 22:284-289. 10.1111/exd.12127.
93. Ahn HJ, Kim K, Il, Kim G, Moon E, Yang SS, Lee J-S. Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals. PLoS One 2011, 6:e28154. 10.1371/journal.pone.0028154.
94. Ishaq M, Evans MDM, Ostrikov KK. Atmospheric pressure gas plasma-induced colorectal cancer cell death is mediated by Nox2-ASK1 apoptosis pathways and oxidative stress is mitigated by Srx-Nrf2 anti-oxidant system. Biochim Biophys Acta 2014, 1843:2827-2837. 10.1016/j.bbamcr.2014.08.011.
95. Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discovery 2013, 12:931-947. 10.1038/nrd4002.
96. Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol 2013, 3:120144. 10.1098/rsob.120144.
97. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000, 97:8841-8848.
98. Dwyer DJ, Belenky P a, Yang JH, MacDonald IC, Martell JD, Takahashi N, et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA 2014, 111:E2100-E2109. 10.1073/pnas.1401876111.